Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $0.51. Xtant Medical shares last traded at $0.51, with a volume of 79,203 shares.
Xtant Medical Trading Down 5.9 %
The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.88 and a current ratio of 2.12. The firm has a 50 day moving average price of $0.53. The company has a market cap of $66.72 million, a P/E ratio of -3.69 and a beta of 0.35.
Institutional Trading of Xtant Medical
A hedge fund recently raised its stake in Xtant Medical stock. Geode Capital Management LLC grew its position in Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT – Free Report) by 70.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 515,006 shares of the medical device company’s stock after buying an additional 212,394 shares during the quarter. Geode Capital Management LLC owned 0.37% of Xtant Medical worth $348,000 as of its most recent SEC filing. Institutional investors own 69.33% of the company’s stock.
About Xtant Medical
Xtant Medical Holdings, Inc provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.
Read More
- Five stocks we like better than Xtant Medical
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Basic Materials Stocks Investing
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Xtant Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical and related companies with MarketBeat.com's FREE daily email newsletter.
